The majority of patients with psoriatic arthritis are not eligible for randomised clinical trials
To identify the proportion of patients with psoriatic arthritis (PsA) who would meet inclusion criteria of the randomised clinical trials that were performed leading up to registration of the tumour necrosis factor inhibitors (TNFi). Data from 329 patients with PsA were obtained from an Icelandic da...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental rheumatology 2018-11, Vol.36 (6), p.1068-1073 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!